论文部分内容阅读
近年来,中国乃至全世界的药品安全危害事件呈现出逐年上升的趋势,导致了很多惨痛的结果,影响了整个社会的和谐。其案件之多,影响之大,前所未有。2012年8月31日,德国格兰泰公司就撒利多胺药物引起的新生儿先天性缺陷作出公开道歉,这一德国历史上最大的医药丑闻,一时引起了整个世界的震惊,也再一次将药品安全问题推向风口浪尖。撒利多胺事件始末撒利多胺,早在上世纪60年代由德国的格兰泰公司生产的一种镇静药物。那时这种药是被用来缓解妇女怀孕初期出现的各种不适症状,比如清晨起床容易恶心呕吐等。然而,在短
In recent years, the drug safety hazards in China and around the world have shown a year-by-year upward trend, leading to many painful results that have affected the harmony of the entire society. Its many cases, the impact of large, unprecedented. On August 31, 2012, the German company Gentley made a public apology for the birth defect of newborns caused by salidamine drug. The biggest medical scandal in Germany’s history temporarily aroused the world’s shock and again Drug safety issues to the cusp. Salidroside Incident Saliquat, a sedative drug that was manufactured by the German company Grantine as early as the 1960s. At that time, this medicine was used to ease the various symptoms of early pregnancy in women, such as getting up easily in the early morning and nausea and vomiting. However, in short